A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 2, 2009, Pages 127-135

  Hosszúfalusi, Nóra ^a   Karcagi, Veronika ^b   Horváth, Rita ^b   Palik, Éva ^a   Várkonyi, Judit ^a   Rajczy, Katalin ^c   Prohászka, Zoltán ^a   Szentirmai, Csaba ^d   Karádi, István ^a   Romics, László ^a   Pánczél, Pál ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^c National Institute of Haematology and Immunology Budapest   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

C peptide secretion; HLA; MIDD; Mitochondrial diabetes

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR1 ANTIGEN; INSULIN; MITOCHONDRIAL DNA; SULFONYLUREA; HLA DR ANTIGEN; PRIMER DNA;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HLA TYPING; HUMAN; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MATERNALLY INHERITED DIABETES AND DEAFNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; BLOOD; FAMILY; GENETICS; GLUCOSE TOLERANCE TEST; HEARING IMPAIRMENT; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MOTHER; PEDIGREE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; C-PEPTIDE; DEAFNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DNA PRIMERS; DNA, MITOCHONDRIAL; FAMILY; FEMALE; GLUCOSE TOLERANCE TEST; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MOTHERS; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 65549148928     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.841     Document Type: Article

References (28)

1. Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1995; 1271: 253-260.
2. van den Ouweland JM, Lemkes HH, Trembath RC, et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu(UUR) gene. Diabetes 1994; 43: 746-751.
3. van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al. Mutation in mitochondrial tRNA(Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-371.
4. Maassen JA, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996; 39: 375-382.
5. Guillausseau PJ, Massin P, Dubois-Laforgue D, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 2001; 134: 721-728.
6. Maassen JA, 't Hart LM, van Essen E, et al. Mitochondrial diabetes. Molecular mechanism and clinical presentation. Diabetes 2004; 53(Suppl. 1): S103-S109.
7. Lien LM, Lee HC, Wang KL, Chiu JC, Chiu HC, Wei YH. Involvement of nervous system in maternally inherited diabetes and deafness (MIDD) with the A3243G mutation of mitochondrial DNA. Acta Neurol Scand 2001; 103: 159-165.
8. Peto TB, Tóth B, Rath P, Jenkins S, Bird A. Ophthalmic manifestation of maternally inherited diabetes and deafness syndrome - case reports. Diabetol Hung 2004; 12: 209-213.
9. Goto Y, Nonaki I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-653.
10. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-968.
11. Leu(UUR) gene mutation. Diabetes 1996; 45: 478-487.
12. Reardon W, Ross RJ, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992; 340: 1376-1379.
13. Oka Y, Katagiri H, Yazaki Y, Murase T, Kobayashi T. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 1993; 342: 527-528.
14. Kobayashi T, Oka Y, Katagiri H, et al. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia 1996; 39: 1196-1200.
15. van Essen EH, Rope BO, Hart LM, et al. HLA-DQ polymorphism and degree of heteroplasmy of the A3243G mitochondrial DNA mutation in maternally inherited diabetes and deafness. Diabet Med 2000; 17: 841-847.
16. Wong L-J, Boles RG. Mitochondrial DNA analysis in clinical laboratory diagnostics. Clin Chim Acta 2005; 354: 1-20.
17. Seissler J, De Sonnaville JJ, Morgenthaler NG, et al. Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 1998; 41: 891-897.
18. Kobayashi T, Nakanishi K, Nakase H, et al. In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Diabetes 1997; 46: 1567-1571.
19. Lynn S, Borthwick GM, Charnley RM, Walker M, Turnbull DM. Heteroplastic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells. Diabetologia 2003; 46: 296-299.
20. Olsson C, Zethelius B, Lagerstrom-Fermer M, Asplund J, Berne C, Landegren U. Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum Mutat 1998; 12: 52-58.
21. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci U S A 1992; 89: 4221-4225.
22. Duchen MR. Section III: Mitochondria, ß-cell function and type 2 diabetes. Diabetes 2004; 53(Suppl. 1): S96-S102.
23. de Andrade PBM, Rubi B, Frigero F, van den Ouweland JMW, Maassen JA, Maechler P. Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia 2006; 49: 1816-1826.
24. Robertson RP, Harmon J, Tran PO, Poitout V. ß-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53(Suppl. 1): S119-S124.
25. Martinou JC, Green DR. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001; 2: 63-67.
26. Hosszúfalusi N, Vatay A, Rajczy K, et al. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 2003; 26: 452-457.
27. Leu(UUR) gene mutation in Japanese patients. Diabetologia 1994; 37: 504-510.
28. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1973.